insights_auto
Pse është ulur ALMKT 2,92%?
Zhytu më thellëchevron_right
ALMKT:EPA
Mauna Kea Technologies SA
0,090 €
arrow_downward
-2,92%(-0,0027) 1D
6 nĂ«n, 12:46:36 m.d., GMT+1 · EUR
search
TĂ« gjitha simbolet
| Me simbole | Çmimi | Ndrysho | % ndryshim |
|---|
insights_autoPo gjenerohen statistikat kryesore për ALMKT...
Hap
0,08 €
I lartë
0,09 €
I ulët
0,08 €
Kapitalizimi i tregut
17,83Â mln
VĂ«llimi mesatar
549,48 mijë
VĂ«llimi
306,13 mijë
Raporti çmim/fitim
0,76
Maksimumi 52-javor
0,23 €
Minimumi 52-javor
0,07 €
Fitimet për aksion
0,12 €
Aksionet në qarkullim
195,26Â mln
Numri i punonjësve
56
Hap
0,08 €
I lartë
0,09 €
I ulët
0,08 €
Kapitalizimi i tregut
17,83Â mln
VĂ«llimi mesatar
549,48 mijë
VĂ«llimi
306,13 mijë
Raporti çmim/fitim
0,76
Maksimumi 52-javor
0,23 €
Minimumi 52-javor
0,07 €
Fitimet për aksion
0,12 €
Aksionet në qarkullim
195,26Â mln
Numri i punonjësve
56
Lajmet
Nga burimet në ueb dhe partnerët e lajmeve
MarketWatch
·
22 minuta më parë
The S&P 500’s most reliable dividend stocks are beating the market. Here’s how to play them.
The Daily News | Texas' Oldest Newspaper
·
38 minuta më parë
Futures-options traders work on the floor at the New York Stock Exchange (NYSE) in New York City
Yahoo Finance
·
31 minuta më parë
Charter’s (NASDAQ:CHTR) Q3 2026 sales beat estimates but stock drops
Reuters
·
8 minuta më parë
Nasdaq futures rise after steep AI selloff as chip stocks stabilize
Profili
Mauna Kea Technologies is a global medical device company focused on endomicroscopy, the field of microscopic imaging during endoscopy procedures. The company researches, develops and markets tools to visualize, detect, and rule out abnormalities including malignant and pre-malignant tumors or lesions in the gastrointestinal and pulmonary tracts.
The company makes Cellvizio, a probe-based Confocal Laser Endomicroscopy system, which provides physicians and researchers with real-time access to histological information during standard endoscopy procedures through high-resolution cellular imaging of internal tissues.
Cellvizio is used in medical applications such as gastrointestinal endoscopy, pulmonology and urology to help physicians diagnose lesions and make accurate treatment decisions in real-time.
Cellvizio went public in July 2011 and trades on the Euronext Paris exchange. Wikipedia
Rreth Mauna Kea Technologies SA
Drejtori ekzekutivSacha Loiseau
Punonjësit56
Themeluar më2000
Selia-
SektoriHealth Care
IndustryMedical device
Uebsajtimaunakeatech.com